BRINER KARIN,ADEVA BARTOLOME MARTA,CASES-THOMAS MANUEL JAVIER,GALKA CHRISTOPHER STANLEY,MARCOS LLORENTE ALICIA,MARTINEZ-GRAU MARIA ANGELES,MAZANETZ MICHAEL PHILIP,O'TOOLE JOHN CUNNINGHAM,RATHMELL RICH,BRINER Karin,ADEVA BARTOLOME Marta,CASES-THOMAS Manuel Javier,GALKA Christopher Stanley,M
申请号：
SI200631496
公开号：
SI1924561T1
申请日:
2006.09.01
申请国别(地区):
SI
年份:
2013
代理人:
摘要：
The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula (I) as selective 5-HT2c receptor agonists for the treatment of 5-HT2c associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety, where, R6 is -NR10R11, where R10 is substituted phenylalkyl or substituted pyridylalkyl and other substituents are as defined in the specification.
